Sharon G Lynch MD

Neurology•Kansas City, KS

Neuroimmunology/Multiple Sclerosis

Professor, Neurology, University Kansas School of Medicine

Join to View Full Profile

3599 Rainbow BlvdKansas City, KS 66103
Phone+1 913-588-6980
Fax+1 913-588-6965

Education & Training

University of Utah HealthPost-Doctoral Fellowship, 1988 - 1991
University of Utah HealthResidency, Neurology, 1985 - 1989
University of Utah HealthInternship, Internal Medicine, 1984 - 1985
University of Alabama School of MedicineClass of 1984

Certifications & Licensure

MO State Medical License 1997 - 2026
KS State Medical License 1991 - 2025
OK State Medical License 2020 - 2021
UT State Medical License 1985 - 1992
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
Completed
Phase 2
Cognitive Effects of Immunomodulatory Drugs in MS Start of enrollment: 2005 Sep 01
Completed
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
Completed
Phase 2
Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS) Start of enrollment: 2009 Sep 01
Completed
Phase 2, Phase 3
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Completed
Phase 3
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS Start of enrollment: 2012 Dec 01
Completed
Phase 1
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
Completed
Phase 2
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Terminated
Phase 3
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME Start of enrollment: 2020 Nov 23
COMPLETED
Join now to see all

Publications & Presentations

PubMed

Mechanisms of Action of Combination Motivational Interviewing-Cognitive Behavior Therapy for Reversing Medication Non-Adherence in Patients With Multiple Sclerosis.
Rachel Schoor, Jared M Bruce, Vincent S Staggs, Andrew T Fox, Amanda Bruce
Journal of Clinical Psychology. 2025-04-03
Dry needling in multiple sclerosis: a scoping review.
Abbas Tabatabaei, Farzan Molaei, Tobia Zanotto, Sharon G Lynch, Jacob Sosnoff
Acupuncture in Medicine. 2025-04-01
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.
John R Corboy, Robert J Fox, Gary Cutter, Eric Engebretson, Aaron Miller
Multiple Sclerosis. 2025-02-01

Press Mentions

Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune EncephalomyelitisJanuary 18th, 2021
Fish Oil Supplements Don't Help MS Patients: StudyFebruary 10th, 2016

Committees

Member, Kansas Palliative Care and Quality of Life Interdisciplianry Advisory Council 2018 - Present
Member, Institutional Review Board for University of KansasMedical Center 2001 - Present

Professional Memberships

American Academy of Neurology - AAN
Fellow